Delic Corp is providing a default status report in accordance with the alternative information guidelines set out in National Policy 12-203 – Management Cease Trade Orders.

Nation’s Largest Ketamine Therapy Provider to Cover Out-Of-Pocket Costs for Veterans Experiencing Treatment-resistant Depression, PTSD and Anxiety

KWC Becomes Largest Ketamine Provider in the U.S. to Offer NAD+, Will be Available to Patients at Six Clinic Locations Beginning May 9

Hosted in Las Vegas, Nevada, the Planet MicroCap Showcase is the premier in-person MicroCap finance event. At this year’s showcase, Stang will deliver a presentation highlighting the Company’s development and outlook for the second half of the year.

Matt Stang, Co-founder and CEO of Delic Corp, will present on the Company’s strategic outlook for the remainder of the year at the Sequire Cannabis and Psychedelic Conference on April 20, 2022 and the Scottsdale Capital Event on April 22-24, 2022.

Federally-licensed research lab received additional 56 Research Exemption to acquire psilocybin mushrooms from Nectar Health Sciences Laboratory Division Inc.

FDA-Approved Spray Treatment Ensures KWC Will Now Serve More Patients than Any Other Ketamine Provider in the U.S. with the Addition of SPRAVATO, Beginning April 1